These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 15075731)

  • 1. Interventional approach to congenital heart disease.
    Holzer R; Hijazi ZM
    Curr Opin Cardiol; 2004 Mar; 19(2):84-90. PubMed ID: 15075731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter treatment of perimembranous ventricular septal defect, secundum atrial septal defect and patent ductus arteriosus in a child.
    Butera G; Piazza L; Hijazi Z; Chessa M; Carminati M
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):775-8. PubMed ID: 17001241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventional pediatric cardiology: device closures.
    Wilkinson JL
    Indian J Pediatr; 2000 Mar; 67(3 Suppl):S30-6. PubMed ID: 11129918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventional pediatric cardiology: device closures.
    Wilkinson JL
    Indian J Pediatr; 2000 Jul; 67(7):507-13. PubMed ID: 10957836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventional catheterization.
    Nakanishi T
    Curr Opin Cardiol; 2000 Jul; 15(4):211-5. PubMed ID: 11139083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric catheter interventions: a year in review 2004-2005.
    Patel HT; Hijazi ZM
    Curr Opin Pediatr; 2005 Oct; 17(5):568-73. PubMed ID: 16160529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter closure of congenital perimembranous ventricular septal defect using the Amplatzer duct occluder 2.
    Zhao LJ; Han B; Zhang JJ; Yi YC; Jiang DD; Lyu JL
    Cardiol Young; 2018 Mar; 28(3):447-453. PubMed ID: 29233213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in surgical and catheter interventions for isolated congenital shunt lesions in the UK and Ireland.
    Farooqi M; Stickley J; Dhillon R; Barron DJ; Stumper O; Jones TJ; Clift PF; Brawn WJ; Drury NE
    Heart; 2019 Jul; 105(14):1103-1108. PubMed ID: 30772822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders.
    Carminati M; Butera G; Chessa M; Drago M; Negura D; Piazza L
    Am J Cardiol; 2005 Dec; 96(12A):52L-58L. PubMed ID: 16399093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter closure of secundum atrial septal defects, a ventricular septal defect, and a patent arterial duct.
    Bilgiç A; Celiker A; Ozkutlu S; Ayabakan C; Karagöz T; Ocal T
    Turk J Pediatr; 2001; 43(1):12-8. PubMed ID: 11297152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the technique of interventional closure of perimembranous ventricular septal defect reduce the incidence of heart block?
    Bentham JR; Gujral A; Adwani S; Archer N; Wilson N
    Cardiol Young; 2011 Jun; 21(3):271-80. PubMed ID: 21281545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present scenario of device closure for congenital heart diseases.
    Vijayalakshmi IB
    J Indian Med Assoc; 2003 Feb; 101(2):86-8. PubMed ID: 12841489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter closure with use of the SHSMA occluder in 180 patients with congenital heart defects: preliminary results.
    Sun WF; Dong ZF; Gong K; Zhang GP; Cui T; Xia YD; Dong J; Shen Y
    Tex Heart Inst J; 2010; 37(5):531-7. PubMed ID: 20978563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer Vascular Plug-II.
    Hua N; Aquino P; Owada CY
    Cardiol Young; 2016 Aug; 26(6):1194-201. PubMed ID: 26498904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Utilities of Pediatric Cardiac Catheterization.
    Moustafa GA; Kolokythas A; Charitakis K; Avgerinos DV
    Curr Cardiol Rev; 2016; 12(4):258-269. PubMed ID: 26926291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous closure of multiple atrial septal defects and patent ductus arteriosus during the same session.
    Odemiş E; Ozyılmaz I; Güzeltaş A
    Turk Kardiyol Dern Ars; 2012 Dec; 40(8):726-8. PubMed ID: 23518889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolysis and its outcome following percutaneous closure of cardiac defects among children and adolescents: a prospective study.
    Amoozgar H; Soltani R; Edraki M; Mehdizadegan N; Mohammadi H; Ajami G; Borzouee M; Naghshzan A; Keshavarz K
    Ital J Pediatr; 2019 Oct; 45(1):128. PubMed ID: 31627743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter closure of secundum atrial septal defects with the new self-centering Amplatzer Septal Occluder.
    Fischer G; Kramer HH; Stieh J; Harding P; Jung O
    Eur Heart J; 1999 Apr; 20(7):541-9. PubMed ID: 10365291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter closure of perimembranous ventricular septal defects using amplatzer asymmetric ventricular septal defect occluder: preliminary experience with 18-month follow up.
    Pinto RJ; Dalvi BV; Sharma S
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):145-52. PubMed ID: 16763998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous treatment of atrial septal defects, muscular ventricular septal defects and patent ductus arteriosus in infants under one year of age.
    Prada F; Mortera C; Bartrons J; Rissech M; Jiménez L; Carretero J; Llevadias J; Araica M
    Rev Esp Cardiol; 2009 Sep; 62(9):1050-4. PubMed ID: 19712627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.